000326
10.3205/000326
urn:nbn:de:0183-0003268
Case Report
The terminal period findings of late-diagnosed fibrodysplasia ossificans progressiva
Befunde im Endstadium einer spät diagnostizierten Fibrodysplasia ossificans progressiva
Doğan
Doğan
Emrah
E
Dr.
Muğla Sıtkı Koçman University, Faculty of Medicine, Department of Radiology, 228 sok. Obam sitesi No. 15, Kötekli, Menteşe, Muğla, Turkey, Phone: +90 5066619794, Fax: +90 252 2123599Department of Radiology, Muğla Sıtkı Koçman University, Muğla, Turkey
dr_e_dogan@hotmail.com
author
Aydoğmuş
Aydoğmuş
Hüseyin
H
Department of Physical Medicine and Rehabilitation, Muğla Sıtkı Koçman University Education and Research Hospital, Muğla, Turkey
author
Elibol
Elibol
Cenk
C
Department of Radiology, Muğla Sıtkı Koçman University Education and Research Hospital, Muğla, Turkey
author
Aydoğmuş
Aydoğmuş
Sinem
S
Department of Radiology, Muğla Sıtkı Koçman University Education and Research Hospital, Muğla, Turkey
author
German Medical Science GMS Publishing House
Düsseldorf
610
Radiology
20210619
20220524
20230711
engl
This is an Open Access article distributed under the terms of the Creative Commons Attribution 4.0 License.
Dieser Artikel ist ein Open-Access-Artikel und steht unter den Lizenzbedingungen der Creative Commons Attribution 4.0 License (Namensnennung).
1612-3174
21
GMS German Medical Science
GMS Ger Med Sci
12
Fibrodysplasia ossificans progressiva (FOP) ist eine autosomal-dominante, seltene Krankheit, die sich durch Fußdeformitäten und gleichzeitige heterotope Verknöcherungen auszeichnet. Wird die Krankheit nicht frühzeitig diagnostiziert und medikamentös behandelt, sind die Aussichten für die Patienten theoretisch schlecht. Die Diagnose erfolgt in der Regel in einem frühen Alter der Patienten. Daher ist es selten, einen unbehandelten Patienten im Endstadium anzutreffen. Unser Fall war einzigartig, weil er das klinische Bild und die atypische radiologische Verteilung bei einer 20-jährigen, unheilbar kranken, unbehandelten Patientin zeigte. Sie hatte einen Hallux valgus, heterotope Verknöcherungen und multiple Osteochondrome, die in der rechten Clavicula, dem hinteren Bogen der 9. Rippe und beidseitig in Tibia und Fibula entdeckt wurden. Heterotopische Verknöcherungen in den Weichteilen des Halses waren untypischerweise nicht vorhanden. Handdeformitäten, Herzanomalien oder geistige Entwicklungsstörungen wurden nicht beobachtet. Es handelte sich um einen sporadischen Fall. Das Auftreten neurologischer Symptome war ebenfalls atypisch.
Fibrodysplasia ossificans progressiva (FOP) is an autosomal dominant rare disease characterized by foot deformities and concomitant heterotopic ossifications. Theoretically, in the absence of early diagnosis and medication, the patient’s outcome will be poor. The patients are usually diagnosed at an early age. Hence, encountering a non-treated and terminal-period patient is rare. Our case was unique because it showed the clinical picture and atypical radiological distribution of a 20-year-old, terminally ill untreated female patient. She had hallux valgus, heterotopic ossifications and multiple osteochondromas that were detected in the right clavicula, the posterior arch of the 9th rib, the bilateral tibia and fibula. Atypically, heterotopic ossifications were not present in the soft tissues of the neck. Hand deformity, cardiac anomaly, or mental retardation was not observed. It was a sporadic case. The presentation with neurological symptoms was also atypical.
IntroductionFOP is a rare disease with an incidence of 1/2,000,000 . Most of the patients are sporadic cases resulting from new mutations, although FOP is an autosomal dominant disease . The disabilities resulting from progressive heterotopic calcifications and congenital big toe anomalies (especially hallux valgus) constitute the main picture of FOP. Osteochondromas and atypical congenital malformations are the most common accompanying findings . Infection, immunization, trauma and surgical procedures can trigger heterotopic calcifications . There is no known effective treatment method for FOP so far . However, early diagnosis is essential for decelerating progression, passing the acute flare-ups more easily and preventing unnecessary operative interventions . Our case was a late-diagnosed patient who did not take palliative or curative treatment. We present the case of a 20-year-old female patient accompanied by the clinical and radiological findings.
Case descriptionA 20-year-old female patient was admitted to the hospital with restrictions of joint movement, back and neck pain, and difficulty in walking. In the history of the patient, she was considered a normal newborn since there was no developmental anomaly. The initial problems started with swelling in the back at four years old. At the end of the first decade, complaints of severe pain, joint stiffness, and swelling in the back and extremities became obvious. The patient visited many hospitals without a diagnosi<![CDATA[s b</PlainText></TextGroup>eing made. However, she did not take any treatment except analgesics (NSAIDs, acetaminophen, paracetamol) and various palliative drugs (morphine, midazolam), especially during exacerbation and pain attacks. FOP was first suspected in 2015, taking into account hallux valgus and atypical ossifications. The genetic test performed in an external medical center had confirmed the FOP diagnosis.</Pgraph><Pgraph>The patient had a history of epileptic seizures that started in 2016. The first attack started with the blinking of both eyes, locking in the teeth, loss of consciousness, and spasm in the arms. Except for the bite mark on the patient’s tongue, the first post-seizure neurological examination was completely normal. No acute pathology was observed in the cranial BT. Tegretol at a dose of 200 mg twice a day has been prescribed. Until 2018, when the patient was admitted to the emergency department with recurrent epileptic seizures, no attack was noted for a long time. From the anamnesis, it was understood that the patient had been hospitalized in the general surgery ward due to abdominal muscle rupture two days before the seizure and had not taken epilepsy drugs for this reason. Thus, recurrence of seizures was attributed <TextGroup><PlainText>to the</PlainText></TextGroup> lack of medication.</Pgraph><Pgraph>Emergency treatment consisted of the infusion of 5 ampoules of phenytoin. Brain CT performed at this time was normal. At the patient’s discharge, Tegretol 200 mg was increased to one and a half tablets twice a day. Despite restarting the medication, the patient had 3 attacks between January and April 2018.</Pgraph><Pgraph>In October 2018, subarachnoid and interhemisph<TextGroup><PlainText>eric h</PlainText></TextGroup>emorrhage occurred as a result of the trauma relate<TextGroup><PlainText>d to f</PlainText></TextGroup>ainting and falling. The hemorrhage spontaneously resorbed.</Pgraph><Pgraph>In the obstetrical and gynecological history of the patient, recurrent abortions at five and two months in 2016 and 2018 were reported. After abortions, the patient was followed up for secondary amenorrhea. Her hormone profile was normal. Uterus didelphis, right uterine horn stenosis, fundal myoma uteri (size 51x47 mm) and a left ovarian follicle cyst (size 25 mm) were the detected gynecological pathologies in ultrasound and hysterosalpingography. Secondary amenorrhea was attributed to multiple abortuses, anatomical pathologies and epileptical drug.</Pgraph><Pgraph>The patient presented to the physical therapy outpatient clinic several times in January 2016, April 2017, January 2018, and December 2019 because of severe pain. Stretching, opening, and closing exercises were recommended. The physiotherapy program was performed with the continuous passive motion (CPM) machine.</Pgraph><Pgraph>In the pulmonary and cardiac examination, respiratory sounds were bilaterally normal. No rales, rhonchi or pathological cardiac sounds (S1 + S2 + additional sound or murmur) were detected in the auscultation. The abdominal examination was also normal. No abdominal sensitivity, rebounds or defense was found. In the evaluation of the skeletal system from up to down, there was flattening in the neck. The shoulders’ abduction and left knee movement were limited. Difficulty in the extension of the waist and feet was present. Bilateral Babinski reflex was negative. Bilateral edema was present. Venous Doppler USG was requested. There was no vascular pathology. According to radiological algorithm, X-rays were <TextGroup><PlainText>taken first</PlainText></TextGroup>. Following the discovery of abnormalities, chest CT scans were performed. At the result of these evaluations, multiple linear heterotrophic bone formations that cover the chest were seen (paraspinal muscle calcifications). There were bridges between ectopic ossifications (Figure 1 <ImgLink imgNo="1" imgType="figure"/>). Scoliosis, ankylosis in bony structures and thickening of the paravertebral ligaments were present. Unlike the expected course of the disease, heterotopic neck ossifications were not detected (Figure 2a <ImgLink imgNo="2" imgType="figure"/>). Multiple osteochondromas in the right clavicle (Figure 1 <ImgLink imgNo="1" imgType="figure"/>, Figure 2a <ImgLink imgNo="2" imgType="figure"/>), the posterior arch of the 9<Superscript>th</Superscript> rib (Figure 1 <ImgLink imgNo="1" imgType="figure"/>) with bridge ossification<TextGroup><PlainText>s (</PlainText></TextGroup>Figure 2b <ImgLink imgNo="2" imgType="figure"/>), metaphysis location of the right femur, distal diaphysis of the left femur, proximal metaphysis of the right femur, and fibula head (Figure 2c <ImgLink imgNo="2" imgType="figure"/>) were seen. Hallux valgus anomaly was present in both feet (Figur<TextGroup><PlainText>e 2</PlainText></TextGroup>d <ImgLink imgNo="2" imgType="figure"/>). Table 1 <ImgLink imgNo="1" imgType="table"/> shows common, ancillary and uncommon findings.</Pgraph><Pgraph>CT images of the axial section showed that the heterotopic ossifications overlapped with the perithoracic muscle lines. The subcutaneous regions were intact (Figure 3 <ImgLink imgNo="3" imgType="figure"/>).</Pgraph><Pgraph>The only treatment recommended to the patient was follow-up and steroids at the time of the flare-ups. The patient consent form was signed on 18 April 2020 by the patient herself.</Pgraph></TextBlock>
<TextBlock linked="yes" name="Discussion">
<MainHeadline>Discussion</MainHeadline><Pgraph>FOP is a rare genetic disease characterized by progressive ectopic pathologic bone formations in skeletal muscles resulting from trauma or infection <TextLink reference="6"></TextLink>. It is also called ‘Munchmeyer’s disease’ or ‘myositis ossificans progressive’ <TextLink reference="7"></TextLink>, <TextLink reference="8"></TextLink>. Congenital foot anomalies are characteristic <TextLink reference="9"></TextLink>. John Freke published the first scientific paper about FOP in 1740. However, FOP was probably first described long before, by Guy Patin <TextLink reference="10"></TextLink>. The first name of this disease was ‘Stoneman’s disease’.</Pgraph><Pgraph>The number of FOP patients in the world is limited. There are currently 800 known patients <TextLink reference="10"></TextLink>. Although calculating the presence of 2,000 alive cases in consideration of the incidence rate, the world population, and the patient’s lifespan, more than half of the patients are not present in medical records.</Pgraph><Pgraph>It is difficult to estimate a precise age, but symptoms seem to begin at around five years of age <TextLink reference="11"></TextLink>. The genetic background of FOP is related to the overexpression of bone morphogenic protein (BMP 4). The mutation affecting the type 1 receptors of this protein activates osteogenesis. The responsible mutational gene from osteogenesis is the ACVR1 (activin A receptor), located in the second chromosome <TextLink reference="12"></TextLink>.</Pgraph><Pgraph>At first, heterotopic ossifications start from the neck and progress to the thoracic and lumbar regions. In other words, FOP has a cranio-caudal evolution <TextLink reference="13"></TextLink>. The sternocleidomastoid muscle is considered the initiation point of ossifications. The muscle groups of the ocular region, tongue, larynx, heart, diaphragm, abdominal wall, and smooth muscles are not involved <TextLink reference="13"></TextLink>. Early diagnosis is essential for avoiding unnecessary surgical intervention, overcoming acute flare-up periods with fewer complications, patient comfort, and slowing down progression <TextLink reference="5"></TextLink>. Our patient was diagnosed 5 years ago at the age of 15 in the terminal period. She had widespread heterotopic ossifications and bridges. Severe contractures were observed. However, heterotopic ossifications were not found in the neck. Thus, the appearance was atypical for FOP.</Pgraph><Pgraph>X-ray images are technically enough for bone and ossification assessment. They can show bone bridges, various skeletal deformities, and the ectopic ossification of soft tissues. Also, hand and foot deformities can easily be evaluated with X-ray imaging <TextLink reference="14"></TextLink>. Advanced radiological imaging can be necessary for more detailed evaluation. CT scans can show ossifications with precision. Magnetic resonance imaging (MRI) is useful to show early-stage lesions, especially before ossifications <TextLink reference="15"></TextLink>. The laboratory values are generally normal <TextLink reference="9"></TextLink>. FOP is diagnosed with clinical and radiological findings. The biopsy is contraindicated because it triggers ossifications <TextLink reference="16"></TextLink>.</Pgraph><Pgraph>The general clinical picture is the combination of congenital anomalies of feet and progressive ossifications. Congenital skeletal anomalies characteristically <TextGroup><PlainText>affect the</PlainText></TextGroup> big toe in all of the cases. These anomalies are deviation (hallux valgus) and rigidity <TextLink reference="1"></TextLink>. Hallux valgus is the indispensable (sine qua non) finding of FOP. Sharp first metatarsal bone and first finger shortness can be present. Besides, some hand deformities associated with FOP can also be found. Common hand deformities are short first metacarpal and clinodactyly in the 5<Superscript>th</Superscript> finger. The cervical vertebra malformation, short wide femoral neck, cardiac conduction defects, deafness, baldness, and moderate mental retardation are other reported anomalies in FOP <TextLink reference="17"></TextLink>. Osteochondromas are seen in 50% of the cases <TextLink reference="10"></TextLink>. Indeed, our patient had multiple osteochondromas in the bilateral leg, ribs, and clavicula.</Pgraph><Pgraph>There are not many diseases in the differential diagnosis with FOP, since the main picture of the disease is clear with foot anomalies and accompanying ossifications. Myositis ossificans as well as endocrinological genetic and non-genetic dystrophies can be considered in the differential diagnosis.</Pgraph><Pgraph>Our patient had multiple osteochondromas. If other findings were not present, hereditary multiple exostoses may be considered <TextLink reference="18"></TextLink>. Probably, the only finding that could be found at birth is hallux valgus, and in this case, FOP should come to mind as a diagnosis. Thus, the genetic test should be recommended to patients with hallux valgus <TextLink reference="19"></TextLink>.</Pgraph><Pgraph>Kitterman reported that 51% of patients with FOP suffered from at least one neurological symptom.</Pgraph><Pgraph>The rate of neurological symptoms in females was higher than in males. Recurrent headache and sensory anomalies include a large proportion of neurological findings detected. According to Kitterman, the finding of recurrent seizures seen in our patient is one of the atypical neurological findings, with an incidence of 2.8% <TextLink reference="20"></TextLink>.</Pgraph><Pgraph>Our patient had secondary amenorrhea due to an unexplained reason. However, in our case it could be related to other causes, since Elsaiti et al. highlighted that secondary amenorrhea was extremely rare compared to primary amenorrhea in FOP <TextLink reference="21"></TextLink>.</Pgraph><Pgraph>Concerning treatment, although steroid and non-steroidal anti-inflammatory drugs are used during acute flare-up periods, there is no evidence of their effectiveness. Besides, steroids have side effects at a high rate. Theoretically, amino bisphosphonates, inhibitors of leukotrienes, and stabilizers of mastocytes are other potential medical instruments preventing inflammatory edema, fibroproliferation, and angiogenesis. Dorsomorphin (BMC type 1 receptor inhibitor) and palovarotene are new generation agents <TextLink reference="13"></TextLink>. Furthermore, radiation therapy has also been tried for heterotopic ossifications <TextLink reference="22"></TextLink>. Genetic studies on the disease are ongoing. However, a satisfactory result has not been obtained yet.</Pgraph><Pgraph>According to the literature, the cause of death is usually complications resulting from vertebral deformations such as respiratory failure, pneumonia, atelectasis, or right cardiac failure <TextLink reference="1"></TextLink>, <TextLink reference="7"></TextLink>. Life expectancy is around the fourth decade <TextLink reference="5"></TextLink>.</Pgraph></TextBlock>
<TextBlock linked="yes" name="Conclusion">
<MainHeadline>Conclusion</MainHeadline><Pgraph>Patients with FOP are generally diagnosed at an early age. Theoretically, in the absence of early diagnosis and medication, the patient’s evolution will be detrimental. Therefore, encountering a non-treated and terminal-period patient is very rare. Our case was unique because it showed the clinical picture and unusual radiological distribution of a 20-year-old, terminally ill untreated female patient.</Pgraph><Pgraph>It was a sporadic case with no family history. The radiological findings have great importance for FOP diagnosis. On the one hand, the absence of ossifications in the neck is very atypical for FOP, and on the other hand, the presence of multiple osteochondromas and diffuse heterotopic ossifications were quite remarkable in our patient.</Pgraph></TextBlock>
<TextBlock linked="yes" name="Notes">
<MainHeadline>Notes</MainHeadline><SubHeadline>Acknowledgments</SubHeadline><Pgraph>We would like to thank Marwa Mouline Dogan for her substantial support.</Pgraph><SubHeadline>Competing interests</SubHeadline><Pgraph>The authors declare that they have no competing interests.</Pgraph></TextBlock>
<References linked="yes">
<Reference refNo="1">
<RefAuthor>Bhansali SP</RefAuthor>
<RefAuthor>Tiwari AD</RefAuthor>
<RefAuthor>Mittal S</RefAuthor>
<RefAuthor>Pareek S</RefAuthor>
<RefAuthor>Nasir I</RefAuthor>
<RefTitle>Fibrodysplasia ossificans progressiva or Munchmeyer's disease: A rare case report</RefTitle>
<RefYear>2021</RefYear>
<RefJournal>Natl J Maxillofac Surg</RefJournal>
<RefPage>120-3</RefPage>
<RefTotal>Bhansali SP, Tiwari AD, Mittal S, Pareek S, Nasir I. Fibrodysplasia ossificans progressiva or Munchmeyer's disease: A rare case report. Natl J Maxillofac Surg. 2021 Jan-Apr;12(1):120-3.
DOI: 10.4103/njms.NJMS_52_19</RefTotal>
<RefLink>https://doi.org/10.4103/njms.NJMS_52_19</RefLink>
</Reference>
<Reference refNo="2">
<RefAuthor>Wang Z</RefAuthor>
<RefAuthor>Wang X</RefAuthor>
<RefAuthor>Liu B</RefAuthor>
<RefAuthor>Hou Y</RefAuthor>
<RefTitle>Fibrodysplasia ossificans progressiva in a young adult with genetic mutation: Case report</RefTitle>
<RefYear>2021</RefYear>
<RefJournal>Medicine (Baltimore)</RefJournal>
<RefPage>e24620</RefPage>
<RefTotal>Wang Z, Wang X, Liu B, Hou Y. Fibrodysplasia ossificans progressiva in a young adult with genetic mutation: Case report. Medicine (Baltimore). 2021 Mar;100(9):e24620.
DOI: 10.1097/MD.0000000000024620</RefTotal>
<RefLink>https://doi.org/10.1097/MD.0000000000024620</RefLink>
</Reference>
<Reference refNo="3">
<RefAuthor>Kaplan FS</RefAuthor>
<RefAuthor>Glaser DL</RefAuthor>
<RefAuthor>Shore EM</RefAuthor>
<RefAuthor>Deirmengian GK</RefAuthor>
<RefAuthor>Gupta R</RefAuthor>
<RefAuthor>Delai P</RefAuthor>
<RefAuthor>Morhart R</RefAuthor>
<RefAuthor>Smith R</RefAuthor>
<RefAuthor>Le Merrer M</RefAuthor>
<RefAuthor>Rogers JG</RefAuthor>
<RefAuthor>Connor JM</RefAuthor>
<RefAuthor>Kitterman JA</RefAuthor>
<RefTitle>The phenotype of fibrodysplasia ossificans progressiva</RefTitle>
<RefYear>2005</RefYear>
<RefJournal>Clin Rev Bone Min Metab</RefJournal>
<RefPage>183-8</RefPage>
<RefTotal>Kaplan FS, Glaser DL, Shore EM, Deirmengian GK, Gupta R, Delai P, Morhart R, Smith R, Le Merrer M, Rogers JG, Connor JM, Kitterman JA. The phenotype of fibrodysplasia ossificans progressiva. Clin Rev Bone Min Metab. 2005;3:183-8.
DOI: 10.1385/BMM:3:3-4:183</RefTotal>
<RefLink>https://doi.org/10.1385/BMM:3:3-4:183</RefLink>
</Reference>
<Reference refNo="4">
<RefAuthor>Shore EM</RefAuthor>
<RefAuthor>Feldman GJ</RefAuthor>
<RefAuthor>Xu M</RefAuthor>
<RefAuthor>Kaplan FS</RefAuthor>
<RefTitle>The genetics of fibrodysplasia ossificans progressiva</RefTitle>
<RefYear>2005</RefYear>
<RefJournal>Clinic Rev Bone Miner Metab</RefJournal>
<RefPage>201-4</RefPage>
<RefTotal>Shore EM, Feldman GJ, Xu M, Kaplan FS. The genetics of fibrodysplasia ossificans progressiva. Clinic Rev Bone Miner Metab. 2005;(3):201-4. DOI: 10.1385/BMM:3:3-4:201</RefTotal>
<RefLink>https://doi.org/10.1385/BMM:3:3-4:201</RefLink>
</Reference>
<Reference refNo="5">
<RefAuthor>Baidoo RO</RefAuthor>
<RefAuthor>Dayie MS</RefAuthor>
<RefTitle>Fibrodysplasia ossificans progressiva: a case report</RefTitle>
<RefYear>2016</RefYear>
<RefJournal>Ghana Med J</RefJournal>
<RefPage>248-50</RefPage>
<RefTotal>Baidoo RO, Dayie MS. Fibrodysplasia ossificans progressiva: a case report. Ghana Med J. 2016 Dec;50(4):248-50.
DOI: 10.4314/gmj.v50i4.8</RefTotal>
<RefLink>https://doi.org/10.4314/gmj.v50i4.8</RefLink>
</Reference>
<Reference refNo="6">
<RefAuthor>Qi Z</RefAuthor>
<RefAuthor>Luan J</RefAuthor>
<RefAuthor>Zhou X</RefAuthor>
<RefAuthor>Cui Y</RefAuthor>
<RefAuthor>Han J</RefAuthor>
<RefTitle>Fibrodysplasia ossificans progressiva: Basic understanding and experimental models</RefTitle>
<RefYear>2017</RefYear>
<RefJournal>Intractable Rare Dis Res</RefJournal>
<RefPage>242-8</RefPage>
<RefTotal>Qi Z, Luan J, Zhou X, Cui Y, Han J. Fibrodysplasia ossificans progressiva: Basic understanding and experimental models. Intractable Rare Dis Res. 2017 Nov;6(4):242-8.
DOI: 10.5582/irdr.2017.01055</RefTotal>
<RefLink>https://doi.org/10.5582/irdr.2017.01055</RefLink>
</Reference>
<Reference refNo="7">
<RefAuthor>Nitek Z</RefAuthor>
<RefAuthor>Czwojdziński A</RefAuthor>
<RefAuthor>Wolf-Kuś A</RefAuthor>
<RefAuthor>Walecki J</RefAuthor>
<RefTitle>Computed tomography in the diagnosis of myositis ossificans - case report</RefTitle>
<RefYear>2014</RefYear>
<RefJournal>Pol J Radiol</RefJournal>
<RefPage>296-8</RefPage>
<RefTotal>Nitek Z, Czwojdziński A, Wolf-Kuś A, Walecki J. Computed tomography in the diagnosis of myositis ossificans - case report. Pol J Radiol. 2014;79:296-8. DOI: 10.12659/PJR.890511</RefTotal>
<RefLink>https://doi.org/10.12659/PJR.890511</RefLink>
</Reference>
<Reference refNo="8">
<RefAuthor>Berrada L</RefAuthor>
<RefAuthor>Rhouda H</RefAuthor>
<RefAuthor>Sahli M</RefAuthor>
<RefAuthor>Sefiani A</RefAuthor>
<RefAuthor>Kriouile Y</RefAuthor>
<RefTitle>Fibroplasia Ossificans Progressiva Or Munchmeyer's Disease: Pediatric Case Report</RefTitle>
<RefYear>2020</RefYear>
<RefJournal>wjpmr</RefJournal>
<RefPage>19-22</RefPage>
<RefTotal>Berrada L, Rhouda H, Sahli M, Sefiani A,Kriouile Y. Fibroplasia Ossificans Progressiva Or Munchmeyer's Disease: Pediatric Case Report. wjpmr. 2020;6(9):19-22.</RefTotal>
</Reference>
<Reference refNo="9">
<RefAuthor>She D</RefAuthor>
<RefAuthor>Li R</RefAuthor>
<RefAuthor>Fang P</RefAuthor>
<RefAuthor>Zong G</RefAuthor>
<RefAuthor>Xue Y</RefAuthor>
<RefAuthor>Zhang K</RefAuthor>
<RefTitle>Serum osteocalcin level is associated with the mortality in Chinese patients with Fibrodysplasia ossificans progressiva aged ≤18 years at diagnosis</RefTitle>
<RefYear>2020</RefYear>
<RefJournal>BMC Musculoskelet Disord</RefJournal>
<RefPage>152</RefPage>
<RefTotal>She D, Li R, Fang P, Zong G, Xue Y, Zhang K. Serum osteocalcin level is associated with the mortality in Chinese patients with Fibrodysplasia ossificans progressiva aged ≤18 years at diagnosis. BMC Musculoskelet Disord. 2020 Mar;21(1):152. DOI: 10.1186/s12891-020-3170-3</RefTotal>
<RefLink>https://doi.org/10.1186/s12891-020-3170-3</RefLink>
</Reference>
<Reference refNo="10">
<RefAuthor>Wang D</RefAuthor>
<RefTitle>Fibrodysplasia Ossificans Progressiva in China, An Updated Review</RefTitle>
<RefYear>2019</RefYear>
<RefJournal>Int J Biomed Sci</RefJournal>
<RefPage>1-5</RefPage>
<RefTotal>Wang D. Fibrodysplasia Ossificans Progressiva in China, An Updated Review. Int J Biomed Sci. 2019;(15)1:1-5.</RefTotal>
</Reference>
<Reference refNo="13">
<RefAuthor>Shah ZA</RefAuthor>
<RefAuthor>Rausch S</RefAuthor>
<RefAuthor>Arif U</RefAuthor>
<RefAuthor>El Yafawi B</RefAuthor>
<RefTitle>Fibrodysplasia ossificans progressiva (stone man syndrome): a case report</RefTitle>
<RefYear>2019</RefYear>
<RefJournal>J Med Case Rep</RefJournal>
<RefPage>364</RefPage>
<RefTotal>Shah ZA, Rausch S, Arif U, El Yafawi B. Fibrodysplasia ossificans progressiva (stone man syndrome): a case report. J Med Case Rep. 2019 Dec;13(1):364. DOI: 10.1186/s13256-019-2297-z</RefTotal>
<RefLink>https://doi.org/10.1186/s13256-019-2297-z</RefLink>
</Reference>
<Reference refNo="11">
<RefAuthor>Ahmed W</RefAuthor>
<RefAuthor>Safdar A</RefAuthor>
<RefAuthor>Ahmed I</RefAuthor>
<RefAuthor>Ahmed N</RefAuthor>
<RefTitle>Fibro Dysplasia Ossificans Progressiva</RefTitle>
<RefYear>2019</RefYear>
<RefJournal>J Ayub Med Coll Abbottabad</RefJournal>
<RefPage>123-6</RefPage>
<RefTotal>Ahmed W, Safdar A, Ahmed I, Ahmed N. Fibro Dysplasia Ossificans Progressiva. J Ayub Med Coll Abbottabad. 2019 Jan-Mar;31(1):123-6.</RefTotal>
</Reference>
<Reference refNo="12">
<RefAuthor>Akyuz G</RefAuthor>
<RefAuthor>Gencer-Atalay K</RefAuthor>
<RefAuthor>Ata P</RefAuthor>
<RefTitle>Fibrodysplasia ossificans progressiva: lessons learned from a rare disease</RefTitle>
<RefYear>2019</RefYear>
<RefJournal>Curr Opin Pediatr</RefJournal>
<RefPage>716-22</RefPage>
<RefTotal>Akyuz G, Gencer-Atalay K, Ata P. Fibrodysplasia ossificans progressiva: lessons learned from a rare disease. Curr Opin Pediatr. 2019 Dec;31(6):716-22.
DOI: 10.1097/MOP.0000000000000802</RefTotal>
<RefLink>https://doi.org/10.1097/MOP.0000000000000802</RefLink>
</Reference>
<Reference refNo="17">
<RefAuthor>Subramanyam L</RefAuthor>
<RefAuthor>Gowrishankar K</RefAuthor>
<RefAuthor>Shivbalan S</RefAuthor>
<RefAuthor>Balachandran A</RefAuthor>
<RefTitle>Fibrodysplasia ossificans progressiva</RefTitle>
<RefYear>2004</RefYear>
<RefJournal>Indian J Pediatr</RefJournal>
<RefPage>563-4</RefPage>
<RefTotal>Subramanyam L, Gowrishankar K, Shivbalan S, Balachandran A. Fibrodysplasia ossificans progressiva. Indian J Pediatr. 2004 Jun;71(6):563-4. DOI: 10.1007/BF02724306</RefTotal>
<RefLink>https://doi.org/10.1007/BF02724306</RefLink>
</Reference>
<Reference refNo="14">
<RefAuthor>Mishima K</RefAuthor>
<RefAuthor>Kitoh H</RefAuthor>
<RefAuthor>Haga N</RefAuthor>
<RefAuthor>Nakashima Y</RefAuthor>
<RefAuthor>Kamizono J</RefAuthor>
<RefAuthor>Katagiri T</RefAuthor>
<RefAuthor>Susami T</RefAuthor>
<RefAuthor>Matsushita M</RefAuthor>
<RefAuthor>Ishiguro N</RefAuthor>
<RefTitle>Radiographic characteristics of the hand and cervical spine in fibrodysplasia ossificans progressiva</RefTitle>
<RefYear>2014</RefYear>
<RefJournal>Intractable Rare Dis Res</RefJournal>
<RefPage>46-51</RefPage>
<RefTotal>Mishima K, Kitoh H, Haga N, Nakashima Y, Kamizono J, Katagiri T, Susami T, Matsushita M, Ishiguro N. Radiographic characteristics of the hand and cervical spine in fibrodysplasia ossificans progressiva. Intractable Rare Dis Res. 2014 May;3(2):46-51. DOI: 10.5582/irdr.2014.01009</RefTotal>
<RefLink>https://doi.org/10.5582/irdr.2014.01009</RefLink>
</Reference>
<Reference refNo="15">
<RefAuthor>Al Mukaddam M</RefAuthor>
<RefAuthor>Rajapakse CS</RefAuthor>
<RefAuthor>Pignolo RJ</RefAuthor>
<RefAuthor>Kaplan FS</RefAuthor>
<RefAuthor>Smith SE</RefAuthor>
<RefTitle>Imaging assessment of fibrodysplasia ossificans progressiva: Qualitative, quantitative and questionable</RefTitle>
<RefYear>2018</RefYear>
<RefJournal>Bone</RefJournal>
<RefPage>147-52</RefPage>
<RefTotal>Al Mukaddam M, Rajapakse CS, Pignolo RJ, Kaplan FS, Smith SE. Imaging assessment of fibrodysplasia ossificans progressiva: Qualitative, quantitative and questionable. Bone. 2018 Apr;109:147-52. DOI: 10.1016/j.bone.2017.08.011</RefTotal>
<RefLink>https://doi.org/10.1016/j.bone.2017.08.011</RefLink>
</Reference>
<Reference refNo="16">
<RefAuthor>Kaliya-Perumal AK</RefAuthor>
<RefAuthor>Carney TJ</RefAuthor>
<RefAuthor>Ingham PW</RefAuthor>
<RefTitle>Fibrodysplasia ossificans progressiva: current concepts from bench to bedside</RefTitle>
<RefYear>2020</RefYear>
<RefJournal>Dis Model Mech</RefJournal>
<RefPage>dmm046441</RefPage>
<RefTotal>Kaliya-Perumal AK, Carney TJ, Ingham PW. Fibrodysplasia ossificans progressiva: current concepts from bench to bedside. Dis Model Mech. 2020 Sep;13(9):dmm046441.
DOI: 10.1242/dmm.046441</RefTotal>
<RefLink>https://doi.org/10.1242/dmm.046441</RefLink>
</Reference>
<Reference refNo="20">
<RefAuthor>Kitterman JA</RefAuthor>
<RefAuthor>Strober JB</RefAuthor>
<RefAuthor>Kan L</RefAuthor>
<RefAuthor>Rocke DM</RefAuthor>
<RefAuthor>Cali A</RefAuthor>
<RefAuthor>Peeper J</RefAuthor>
<RefAuthor>Snow J</RefAuthor>
<RefAuthor>Delai PL</RefAuthor>
<RefAuthor>Morhart R</RefAuthor>
<RefAuthor>Pignolo RJ</RefAuthor>
<RefAuthor>Shore EM</RefAuthor>
<RefAuthor>Kaplan FS</RefAuthor>
<RefTitle>Neurological symptoms in individuals with fibrodysplasia ossificans progressiva</RefTitle>
<RefYear>2012</RefYear>
<RefJournal>J Neurol</RefJournal>
<RefPage>2636-43</RefPage>
<RefTotal>Kitterman JA, Strober JB, Kan L, Rocke DM, Cali A, Peeper J, Snow J, Delai PL, Morhart R, Pignolo RJ, Shore EM, Kaplan FS. Neurological symptoms in individuals with fibrodysplasia ossificans progressiva. J Neurol. 2012 Dec;259(12):2636-43. DOI: 10.1007/s00415-012-6562-y</RefTotal>
<RefLink>https://doi.org/10.1007/s00415-012-6562-y</RefLink>
</Reference>
<Reference refNo="21">
<RefAuthor>Elsaiti MS</RefAuthor>
<RefAuthor>Gerryo SE</RefAuthor>
<RefTitle>Fibrodysplasia ossificans progressiva and its association with primary amenorrhea</RefTitle>
<RefYear>2001</RefYear>
<RefJournal>Jamahiriya Med J</RefJournal>
<RefPage>77</RefPage>
<RefTotal>Elsaiti MS, Gerryo SE. Fibrodysplasia ossificans progressiva and its association with primary amenorrhea. Jamahiriya Med J. 2001;1(2):77.</RefTotal>
</Reference>
<Reference refNo="18">
<RefAuthor>Wininger AE</RefAuthor>
<RefAuthor>Chhabra BN</RefAuthor>
<RefAuthor>Haigler RE</RefAuthor>
<RefAuthor>Hanson DS</RefAuthor>
<RefAuthor>Scott AC</RefAuthor>
<RefTitle>The Incidence of Vertebral Exostoses in Multiple Hereditary Exostoses and Recommendations for Spinal Screening</RefTitle>
<RefYear>2021</RefYear>
<RefJournal>J Pediatr Orthop</RefJournal>
<RefPage>e226-e231</RefPage>
<RefTotal>Wininger AE, Chhabra BN, Haigler RE, Hanson DS, Scott AC. The Incidence of Vertebral Exostoses in Multiple Hereditary Exostoses and Recommendations for Spinal Screening. J Pediatr Orthop. 2021 Mar;41(3):e226-e231.
DOI: 10.1097/BPO.0000000000001749</RefTotal>
<RefLink>https://doi.org/10.1097/BPO.0000000000001749</RefLink>
</Reference>
<Reference refNo="19">
<RefAuthor>Kannu P</RefAuthor>
<RefAuthor>Levy CE</RefAuthor>
<RefTitle>Evolving Management of Fibrodysplasia Ossificans Progressiva</RefTitle>
<RefYear>2021</RefYear>
<RefJournal>J Pediatr</RefJournal>
<RefPage>S9-S15</RefPage>
<RefTotal>Kannu P, Levy CE. Evolving Management of Fibrodysplasia Ossificans Progressiva. J Pediatr. 2021 May;232S:S9-S15.
DOI: 10.1016/j.jpeds.2021.02.037</RefTotal>
<RefLink>https://doi.org/10.1016/j.jpeds.2021.02.037</RefLink>
</Reference>
<Reference refNo="22">
<RefAuthor>Lee A</RefAuthor>
<RefAuthor>Maani EV</RefAuthor>
<RefAuthor>Amin NP</RefAuthor>
<RefTitle>Radiation Therapy For Heterotopic Ossification Prophylaxis</RefTitle>
<RefYear>2021</RefYear>
<RefBookTitle>StatPearls</RefBookTitle>
<RefPage></RefPage>
<RefTotal>Lee A, Maani EV, Amin NP. Radiation Therapy For Heterotopic Ossification Prophylaxis. In: StatPearls. Treasure Island, FL: StatPearls Publishing; 2021. [last updated 2020 Oct 7]. Available from: https://www.ncbi.nlm.nih.gov/books/NBK493155/</RefTotal>
<RefLink>https://www.ncbi.nlm.nih.gov/books/NBK493155/</RefLink>
</Reference>
</References>
<Media>
<Tables>
<Table format="png">
<MediaNo>1</MediaNo>
<MediaID>1</MediaID>
<Caption><Pgraph><Mark1>Table 1: Common, ancillary and uncommon findings</Mark1></Pgraph></Caption>
</Table>
<NoOfTables>1</NoOfTables>
</Tables>
<Figures>
<Figure format="png" height="524" width="1490">
<MediaNo>1</MediaNo>
<MediaID>1</MediaID>
<Caption><Pgraph><Mark1>Figure 1: 3D reconstruction images; the extra-skeletal bone formations and heterotopic ossifications around the chest, clavicular osteochondroma in the middle part of right clavicula, compact bone formations along with the vertebral axis</Mark1></Pgraph></Caption>
</Figure>
<Figure format="png" height="1206" width="1281">
<MediaNo>2</MediaNo>
<MediaID>2</MediaID>
<Caption><Pgraph><Mark1>Figure 2: X-ray graphs; a) atypically no calcifications or ossifications in the neck, right clavicular osteochondroma; b) heterotopic ossifications and bone formations around the chest (arrowhead), compact bone formations along with vertebral axis, clavicular osteochondroma; c) multiple osteochondromas located around the knee joint; d) hallux valgus anomal</Mark1></Pgraph></Caption>
</Figure>
<Figure format="png" height="586" width="794">
<MediaNo>3</MediaNo>
<MediaID>3</MediaID>
<Caption><Pgraph><Mark1>Figure 3: Axial CT images show heterotopic ossifications in the paravertebral and the perithoracic areas; a) upper thoracic level; b) subcarinal level; c) lower thoracic level; d) upper abdominal level</Mark1></Pgraph></Caption>
</Figure>
<NoOfPictures>3</NoOfPictures>
</Figures>
<InlineFigures>
<NoOfPictures>0</NoOfPictures>
</InlineFigures>
<Attachments>
<NoOfAttachments>0</NoOfAttachments>
</Attachments>
</Media>
</OrigData>
</GmsArticle>]]></plaintext></textgroup></pgraph></textblock></origdata></gmsarticle>